WHO releases medical warning on fake vials of Covishield vaccines

There are concerns regarding the authenticity of Covishield reaching patients in India, as fraudulent vials of the Covid-19 vaccine developed by Oxford-AstraZeneca and manufactured by Serum Institute of India have been reported (SII).

The World Health Organization’s (WHO) global surveillance and monitoring system for substandard and fake medical products identified fake Covishield in India and Uganda, despite the Union government’s efforts to provide genuine coronavirus vaccines through transparent procurement and supply systems and the technology-backed CoWin platform for administration.

WHO on Tuesday issued a medical product alert referring to fake Covishield in South-East Asia and Africa. The fake products were reported to it in July and August, the apex global public health agency said. SII, the Indian producer of Covishield, had confirmed that some vaccine vials reported at the patient-level were fake, according to WHO.

The health agency urged India to increase vigilance on hospitals, clinics, health centres, wholesalers, distributors, pharmacies, and other suppliers of medical products. WHO has also asked for increased vigilance within supply chains of countries and regions likely to be affected by these fake products.

The products identified are confirmed as “falsified” on the basis that they deliberately or fraudulently misrepresent their identity, composition, or source.

In India, Covishield 2ml was identified though SII does not produce the vaccine in 2ml (four doses). In Uganda, Covishield with Batch 4121Z040 and the expiry date (10.08.2021) was found, which SII confirmed to WHO was fake.

“Genuine Covishield vaccine is indicated for active immunisation of individuals 18 years or older for the prevention of coronavirus disease caused by the SARS-CoV-2 virus. The use of genuine covid-19 vaccines should be in accordance with official guidance from national regulatory authorities,” WHO said.

“Falsified covid-19 vaccines pose a serious risk to global public health and place an additional burden on vulnerable populations and health systems. It is important to detect and remove these falsified products from circulation to prevent harm to patients,” it said.

Medically Speaking Team

Share
Published by
Medically Speaking Team

Recent Posts

The Hidden Costs of Excessive Screen Time: How It Impacts Your Child’s Behavior and What You Can Do About It

Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…

6 hours ago

Transform Your Heart Health: Simple Everyday Diet and Lifestyle Changes for a Happier, Stronger Heart

Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…

6 hours ago

“Unraveling the Truth: Do Brain Tumours Only Affect Older Adults? Debunking Myths and Shedding Light on a Complex Condition”

This article explores the common misconception that brain tumours primarily affect older adults, revealing the…

6 hours ago

“Revolutionary Breakthrough: First-Ever Ovarian Cancer Vaccine Set to Transform Women’s Health and Combat a Silent Killer”

The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…

7 hours ago

“Battling the Monsoon Surge: Essential Strategies to Prevent Dengue and Chikungunya Infections in Delhi”

As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…

7 hours ago

NATURAL vs CHEMICAL SKINCARE: THE ESSENTIAL GUIDE TO CHOOSING WHAT’S BEST FOR YOUR SKIN

Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…

7 hours ago